NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

藥物釋放型性支架(DES):醫療設備開發平台評估(2020年)

Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 967332
出版日期 內容資訊 英文 162 Pages
訂單完成後即時交付
價格
藥物釋放型性支架(DES):醫療設備開發平台評估(2020年) Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月19日內容資訊: 英文 162 Pages
簡介

本報告提供藥物釋放型性支架(DES)的相關調查,提供開發中產品詳細內容,開發的各階段的產品比較分析,進行中的臨床試驗,產業的最近的趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

  • 藥物釋放型性支架(DES)概要

第3章 開發中的產品

  • 各開發階段的開發中產品
  • 各地區的開發中產品
  • 各法規途徑的開發中產品
  • 各核准預定日的開發中產品
  • 進行中的臨床試驗

第4章 開發中的開發中產品:各企業

  • 藥物釋放型性支架(DES)企業:各開發階段的開發中產品
  • 各開發階段的開發中產品

第5章 企業與產品概要

第6章 最近的開發

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1006EPD

GlobalData's Medical Devices sector report, "Drug Eluting Stents (DES)-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Drug Eluting Stents (DES) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

DES release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Drug Eluting Stents (DES) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

2 Introduction

  • 2.1 Drug Eluting Stents (DES) Overview

3 Products under Development

  • 3.1 Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
  • 3.2 Drug Eluting Stents (DES) - Pipeline Products by Territory
  • 3.3 Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
  • 3.4 Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
  • 3.5 Drug Eluting Stents (DES) - Ongoing Clinical Trials

4 Drug Eluting Stents (DES) - Pipeline Products under Development by Companies

  • 4.1 Drug Eluting Stents (DES) Companies - Pipeline Products by Stage of Development
  • 4.2 Drug Eluting Stents (DES) - Pipeline Products by Stage of Development

5 Drug Eluting Stents (DES) Companies and Product Overview

6 Drug Eluting Stents (DES)- Recent Developments

7 Appendix

List of Tables

List of Tables

  • Table 1: Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
  • Table 2: Drug Eluting Stents (DES) - Pipeline Products by Territory
  • Table 3: Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
  • Table 4: Drug Eluti

List of Figures

List of Figures

  • Figure 1: Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
  • Figure 2: Drug Eluting Stents (DES) - Pipeline Products by Territory
  • Figure 3: Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
  • Figure 4: Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
  • Figure 5: Drug Eluting Stents (DES) - Ongoing Clinical Trials